It has also been shown that HCV activates Nrf2 and that HCCs with the virus present (HCV-positive HCC, or C-HCC) have enhanced p62/Sqstm1 pathways, which promotes metabolic reprogramming and tumor growth in a manner that is reliant on Nrf2. The gene discussed is SQSTM1; the disease is hepatocellular carcinoma.